Critical State of "Remission-Recurrence" of Ulcerative Colitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-19

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will recruit 100 patients with ulcerative colitis in remission for a 6-month non intervention follow-up observation. During the study, their conditions will be recorded truthfully, including general information, disease-related symptoms and signs, inflammatory bowel disease questionnaire, anxiety self-assessment scale, depression self-assessment scale, etc., every month. Collect blood, urine, and stool samples from patients every month for examination. Follow up for each subject until their condition recurs.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prognosis in UC After First Biological

NCT05530122

Ulcerative Colitis

COMPLETED

Clinical Outcome of Treatment of Ulcerative Colitis in Adult

NCT06143163

Ulcerative Colitis

NOT_YET_RECRUITING

Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease

NCT02054533

Crohn's Disease Ulcerative Colitis

COMPLETED

In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative Colitis

NCT02852850

Ulcerative Colitis

UNKNOWN

A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis

NCT03698812

Prospective Study Ulcerative Colitis in Remission

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ulcerative Colitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ulcerative colitis in remission period

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who meet the criteria based on the clinical characteristics of ulcerative colitis patients in the "remission recurrence" critical state, combined with clinical symptoms, are diagnosed with ulcerative colitis through imaging, endoscopy, laboratory, and histopathological examinations;
* Patients with comprehensive laboratory testing indicators.

Exclusion Criteria

* Patients with incomplete case information records;
* Patients who have not completed serological tests;
* Complications including intestinal obstruction, intestinal perforation, toxic megacolon, and severe local stenosis;
* Diagnosed or suspected patients with coexisting uncertain colitis, infectious or ischemic colitis;
* Patients with coexisting local or systemic infections, any malignant diseases, or autoimmune diseases;
* Merge primary diseases such as respiratory, circulatory, neurological, endocrine, and hematological disorders;
* Individuals at risk of developing cancer;
* regnant or lactating women.

Eligible Sex

ALL

Accepts Healthy Volunteers

No